Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies
This article reviews the major clinical trial data that is the basis for the current chemotherapy regimens used as first- and second-line treatments for advanced pancreatic adenocarcinoma. We also review the current ongoing clinical trials, which include the use of agents targeting the oncogenic network signaling of K-Ras, agents targeting the extracellular matrix, and immune therapies.
Source: Therapeutic Advances in Medical Oncology - Category: Cancer & Oncology Authors: Teague, A., Lim, K.-H., Wang-Gillam, A. Tags: Reviews Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Pancreas | Pancreatic Cancer